Position in PFE
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$27,398,898
-$1,804,442 QoQ
Shares Held
1,137,828
+9.4% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#237
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ALPS ADVISORS INC holds $242,744,034 across 9 Drug Manufacturers - General names. PFE ranks #5 (11.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
452,664 | $58,167,324 | |
| 2 | JNJ |
Johnson & Johnson
|
211,287 | $53,660,559 | |
| 3 | ABBV |
AbbVie Inc.
|
146,723 | $36,921,375 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
558,264 | $32,167,171 | |
| 5 | PFE |
Pfizer Inc
This page
|
1,137,828 | $27,398,898 | |
| 6 | LLY |
ELI LILLY & Co
|
14,911 | $17,884,702 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
67,881 | $8,576,085 | |
| 8 | AMGN |
Amgen Inc
|
20,994 | $7,602,347 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,398,898 | 1,137,828 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $29,203,340 | 1,040,005 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $25,947,717 | 1,042,077 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $28,017,884 | 1,099,603 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $23,548,408 | 971,469 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $24,151,807 | 953,110 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $25,125,316 | 947,053 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $23,825,925 | 823,287 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $29,405,468 | 1,050,946 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $30,103,588 | 1,084,814 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $29,604,929 | 1,028,306 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $8,758,537 | 264,050 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $21,255,105 | 579,474 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $24,150,335 | 591,920 | Shares | Other | 2023-05-10 | |
| 2022-12-31 | $31,624,149 | 617,177 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $28,433,715 | 649,765 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $32,193,854 | 614,035 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $3,158,280 | 61,006 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,077,756 | 69,056 | Shares | Other | 2022-02-09 | |
| 2021-09-30 | $83,518,709 | 1,941,844 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $80,754,223 | 2,062,161 | Shares | Other | 2021-08-11 | |
| 2021-03-31 | $55,278,610 | 1,525,769 | Shares | Other | 2021-05-07 | |
| 2020-12-31 | $50,470,190 | 1,371,100 | Shares | Other | 2021-02-03 | |
| 2020-09-30 | $50,608,368 | 1,378,976 | Shares | Other | 2020-11-05 | |
| 2020-06-30 | $48,670,958 | 1,488,407 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $51,244,598 | 1,569,996 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||